Michael N. Dudley, Pharm.D.
Senior Vice President of Research and Development and Chief Scientific Officer

Dr. Dudley has extensive experience in antiinfective drug evaluation research in the pharmaceutical industry and in the academic/clinical settings. Prior to joining Mpex in the fall of 2005, he was Vice President for Preclinical and Clinical Sciences at Diversa Corporation, and prior to that served as Vice President for Pharmacology and Microbiology at Essential Therapeutics/Microcide Pharmaceuticals. Prior to moving to industry in 1997, he conducted research and clinical practice in infectious diseases, including clinical (Phases 1-IV) and pioneering work in the pharmacokinetics/pharmacodynamics of several classes of antibacterial and antiviral agents at the University of Rhode Island and Brown University School of Medicine. He has published over 100 papers and book chapters describing the discovery, pharmacology and clinical therapeutics of antiinfective agents and infectious diseases, and served as an editor and on editorial boards for several peer-reviewed publications. Dr. Dudley earned his doctorate from the University of California San Francisco (UCSF) School of Pharmacy, and completed postdoctoral training at UCSF and Hartford Hospital, Hartford, CT.